Company intelligence
MaxWell Biosystems
Every Cell Has A Story To Tell. Connect to your cells and track their activity, connectivity and maturity.
About MaxWell Biosystems
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.
Verified activity
Signals from MaxWell Biosystems
9 published signals
Presence & Recognition
MaxWell Biosystems is attending the 15th Molecular Mechanisms of Neuronal Connectivity meeting at Cold Spring Harbor Laboratory in September 8–11.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems is attending the 15th Molecular Mechanisms of Neuronal Connectivity meeting at Cold Spring Harbor Laboratory in September 8–11.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems participated in the NeuMoS2026 conference in Zürich, Switzerland, where three speakers will present approaches for automated organoid production, high-throughput screening, and multimodal and electrophysiological phenotyping.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems announced that NeuMoS 2026 is scheduled for three days in Zürich from 16 to 18 September.
Reported by MaxWell Biosystems
Research & Knowledge
MaxWell Biosystems published a new paper in Advanced Healthcare Materials (Wiley) introducing hydroMEA, a human nerve model combining sensory neurons, myelinating Schwann cells, and tissue-like hydrogels.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems will showcase how high-density microelectrode arrays (HD-MEAs) can help bridge the gap in functional insights for human neural organoids and assembloids at the 29th Annual Meeting of the Korean Society for Brain and Neural Sciences (K-Brain 2026)
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems awarded the €2,000 Travel Grant to Arvin Sarkissian, PhD candidate in Fikri Birey’s lab at Emory University for his research on CACNA1A-related epilepsy.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems employee Dr. Annalisa Bucci received the Swiss OphthAWARD 2026 Best Experimental Work award in the Best Experimental Work category for her research on human retina synchronization.
Reported by MaxWell Biosystems
Presence & Recognition
MaxWell Biosystems is represented at the NeuMoS 2026 conference in Zürich, Switzerland, where three speakers will present work on human-derived models for brain development, disease, and genetic diversity.
Reported by MaxWell Biosystems